kairoby Opportune Labs

Taurine

A sulfur-containing compound found in the body and foods, studied for vascular and aging-related effects. Animal longevity findings and human biomarker studies answer different questions.

Dietary supplementLimited human intervention evidence for selected outcomes; human longevity benefit remains unproven.
Kairo editorial · Sources reviewed September 9, 20265 sources
On this page
  1. Overview
  2. What the evidence shows
  3. Safety
  4. Common questions
  5. Questions for your clinician
  6. Sources

Commonly sold as a dietary supplement. Supplements are not reviewed or approved by the FDA the way medicines are.

Overview

Product & regulatory status

Available in supplements and mixed products; the cited research does not establish an approved anti-aging treatment.

Vascular hypothesis

The blood-pressure study linked effects to vascular relaxation and hydrogen-sulfide signalling; that mechanism does not establish a human longevity effect. [1]

What the evidence shows

Short blood-pressure trial

A 12-week placebo-controlled trial randomized 120 adults with prehypertension. Taurine improved clinic and ambulatory blood pressure and vascular-function measures. It did not test prevention of heart attacks, strokes or longer life. [1]

Animal aging findings do not establish human longevity

A 2023 Science study reported lifespan or health-related benefits in experimental animals, alongside human associations. It was not a randomized trial showing that taurine extends human life. [2]

Human associations are inconsistent

A 2025 observational study in 137 men aged 20–93 found no significant association of circulating taurine with age, muscle performance or mitochondrial measures. Observational findings cannot establish benefit or harm from supplementation. [3]

What remains unknown

Long-term clinical benefit and appropriate patient selection remain uncertain. These studies do not establish an anti-aging target.

Safety

Blood-pressure context

The trial lowered blood pressure. Low or treated blood pressure warrants a monitoring discussion; the study did not quantify every medication interaction. [1]

Limited long-term safety inference

Animal experiments cannot establish prolonged supplementation safety in people with different illnesses or medication combinations. [2]

Single ingredient versus mixture

The vascular trial studied controlled oral taurine. Results cannot be assigned to every drink, blend or injectable product. [1]

Understanding product quality

Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [4]

When to seek urgent help

Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [5]

A starting point for discussion

This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.

Common questions

Does an animal lifespan result predict years gained for me?

No. Human clinical benefit needs direct evidence.

Is an energy drink equivalent to the studied supplement?

No. Other ingredients change the exposure and prevent attributing the mixture’s effects to taurine alone.

Questions for your clinician

Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?

Sources

  1. Sun et al.: taurine and blood pressureHypertension, 2016; 120 adults with prehypertension, 12-week randomized placebo-controlled trial and vascular experiments.
  2. Singh et al.: taurine and agingScience, 2023; animal intervention studies and human associations, not a human lifespan trial.
  3. Marcangeli et al.: taurine and human aging markersAging Cell, 2025; observational study of 137 men aged 20–93; no significant relationship with age, muscle performance or mitochondrial measures.
  4. Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
  5. AnaphylaxisMedlinePlus · recognizing an emergency

Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.